Evidence map›Paper›PMID 39654291›Full record

ArticleChemical research in toxicology2025

Physical and Chemical Characterization of Aerosols Produced from Commercial Nicotine Salt-Based E-Liquids.

Trevor Harris

Abstract read
In one paragraph

Article in Chemical research in toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Trevor HarrisOffice of Science, Center for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, Maryland 20993, United States.ORCID 0000-0002-2549-7944

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nicotine salt e-liquids are widely used in pod-style and disposable electronic nicotine delivery systems (ENDS). Studying the physical and chemical properties of their emissions can inform their toxicological impact. A prior companion study reported the harmful and potentially harmful constituents (HPHCs) and aerosol particle sizes produced from laboratory-made nicotine salt and freebase nicotine e-liquids to assess the effects of varying nicotine salts and nicotine protonation. This study reports the HPHCs and aerosol particle sizes for commercial brand nicotine salt and freebase nicotine formulations. Several tobacco, fruit, mint, and menthol flavored e-liquids of varying nicotine concentrations were tested with open and closed pod-style ENDS and a disposable ENDS. The nicotine yields showed a positive correlation with aerosol output, and the aerosol nicotine mass fractions reflected the e-liquid nicotine quantities. Benzene, crotonaldehyde, and 2,3-pentanedione were not detected or quantified in any of the aerosols, whereas acetaldehyde, acrolein, diacetyl, and formaldehyde were each quantified in at least one of the tested conditions. The aerosol particle number concentrations indicated that 97-99% of the aerosols for all the ENDS tested were composed of ultrafine (<0.1 μm) and fine (0.1-1.0 μm) aerosol particle sizes, and the mass median aerodynamic diameters ranged from 1.0 to 1.4 μm. The estimated regional deposition fractions and total respiratory depositions were calculated for all the ENDS conditions using a dosimetry modeling program. The calculations predicted depositions would predominantly occur in the pulmonary and head regions with a low total respiratory deposition (≤41%) calculated for all ENDS tested. This study broadens the availability of high-quality and reliable testing data of popular commercial nicotine salt-based ENDS for the scientific and regulatory communities. In conjunction with the previous work on the model e-liquids, these studies offer an extensive examination of the HPHCs and physical aerosol parameters of nicotine salt e-liquids.

Indexed as

Electronic Nicotine Delivery SystemsNicotineAerosolsParticle SizeSaltsAerosolsNicotineSalts

Identifiers

PMID39654291
PMCPMC11752517

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.